
Sunepitron, also known as CP-93,393 or CP-93,393-1 (HCl), is a combined 5-HT1A рецептор агонист and α2-adrenergic рецептор антагонист. It was previously under development by Pfizer for the treatment of depression and anxiety. It made it to phase III clinical trials before being discontinued.
Sunepitron, also known as CP-93,393 or CP-93,393-1 (HCl), is a combined 5-HT1A receptor agonist and α2-adrenergic receptor antagonist. It was previously under development by Pfizer for the treatment of depression and anxiety. It made it to phase III clinical trials before being discontinued.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.